PubMed Health⌕ Search

Biomedical subjects

S D Craigo

Publications and source records attributed to S D Craigo.

20 records · Page 2Linked to original sources

The role of ultrasound in the diagnosis and management of intrauterine growth retardation.

Ultrasonography has contributed greatly to our ability to diagnose and evaluate fetuses with IUGR. This tool has helped us begin to understand the pathophysiology of the spectrum of disorders we group as growth restriction. The heterogeneity of the syndrome contributes to our inability to find perfect sonographic diagnostic markers, but the information gained from ultrasound still far surpasses that available from other clinical methods. Sonographic estimated fetal weight seems to be the best parameter for diagnosing IUGR, although weight percentiles alone will lead to misdiagnosis or missed diagnosis in some cases. Umbilical artery velocimetry may be the best diagnostic tool in cases in which gestational age is unclear, but sensitivities are not adequate for general screening. Growth measured by change in abdominal circumference also shows promise for diagnosis of IUGR, but is dependent on serial examination. Doppler velocimetry has provided insight into the hemodynamic changes which occur with growth restriction, but findings are poorly predictive of outcome when used for screening. When end diastolic flow is absent or reversed, the incidence of adverse outcome can be high, but adverse outcome can occur without these findings and normal outcomes can occur despite them. The search for methods to improve assessment of fetal status and manage pregnancies with IUGR to maximize fetal outcome will continue.

Female↗

Antenatal therapy of Smith-Lemli-Opitz syndrome.

OBJECTIVES: Smith-Lemli-Opitz syndrome (SLOS) is a recessively inherited disorder caused by an inborn error of cholesterol metabolism that results in deficiency of cholesterol and accumulation of the cholesterol precursor, 7-dehydrocholesterol (DHC) and its epimer, 8-DHC. Affected patients present with congenital anomalies, growth restriction, and mental retardation. Postnatal treatment with cholesterol supplementation has been shown to improve plasma sterol levels and has resulted in improved growth and development in many patients. We hypothesized that prenatal supplementation of cholesterol could potentially arrest some of the adverse consequences of cholesterol deficiency at an earlier stage of development. METHODS: SLOS was diagnosed in the third trimester in a fetus initially identified by sonography with intrauterine growth restriction and ambiguous genitalia and confirmed by elevated levels of 7- and 8-DHC in amniotic fluid. Antenatal supplementation of cholesterol was provided by fetal intravenous and intraperitoneal transfusions of fresh frozen plasma (cholesterol level = 219 mg/dl). RESULTS: The in utero transfusions resulted in increased levels of fetal cholesterol, as measured in blood samples obtained by cordocentesis. In addition, fetal red cell mean corpuscular volume rose, which further indicated that the exogenous cholesterol was incorporated into the fetal erythrocytes. CONCLUSIONS: Antenatal treatment of SLOS by cholesterol supplementation is feasible and results in improvement in fetal plasma cholesterol levels and fetal red cell volume. SLOS may be added to the growing list of human genetic disorders for which prenatal diagnosis is available and therapeutic intervention may be possible.

Cholesterol↗